{
  "schemaVersion": 1,
  "organisationId": "O-c5bdeb2d60644edda79db0d28667c2da",
  "slug": "cencora",
  "name": "Cencora, Inc.",
  "updatedAt": "2026-03-19T06:14:10.735834Z",
  "sections": [
    {
      "type": "OVERVIEW",
      "text": "Cencora, Inc. is a global pharmaceutical sourcing, distribution, and services company in the healthcare sector. It works with healthcare providers and pharmaceutical and biotechnology manufacturers to improve patient access to products and increase the efficiency of the pharmaceutical supply chain across human and animal health. Its offerings include brand-name, specialty, and generic pharmaceuticals; over-the-counter healthcare products; home healthcare supplies and equipment; and a range of services such as logistics, inventory management, reimbursement support, consulting, regulatory and pharmacovigilance services, pharmacy automation, and packaging solutions. The company operates through U.S. and international healthcare solutions businesses, serving customers through a geographically diverse network in the United States and select global markets, with international operations that include pharmaceutical wholesale, commercialization, and related services primarily in Europe and Canada. [P-6a5e1f3536af4dfe80c9097267866630][P-4ada030b0cd84eb2af4fb7ad86086b3f][P-b76378d9a8db4333aba49654008953ec]\n\nCencora states that its purpose is to “create healthier futures.” The company reported fiscal 2024 revenue of $293.96 billion, and it says it has more than 46,000 team members worldwide, a local presence in more than 50 countries, and more than 1,300 office locations and distribution centers globally. The company adopted the Cencora name in 2023, replacing AmerisourceBergen. [https://www.cencora.com/about][T-4a61a9f38a33463ab15be5df3f1fd331][https://www.cencora.com/global-reach][P-22e2057c33174f1aa773e4814d8b4a30]\n[P-6a5e1f3536af4dfe80c9097267866630][P-4ada030b0cd84eb2af4fb7ad86086b3f][P-b76378d9a8db4333aba49654008953ec][T-4a61a9f38a33463ab15be5df3f1fd331][P-22e2057c33174f1aa773e4814d8b4a30][https://www.cencora.com/about][https://www.cencora.com/global-reach]",
      "updatedAt": "2026-03-19T06:14:10.735834Z"
    },
    {
      "type": "PRODUCTS",
      "text": "Cencora’s products are concentrated in pharmaceutical and healthcare distribution. The company says it distributes brand-name, specialty brand-name, and generic pharmaceuticals, along with over-the-counter healthcare products and home healthcare supplies and equipment.[P-6a5e1f3536af4dfe80c9097267866630] Within specialty care, it also distributes physician-administered products such as plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty pharmaceutical products, and it provides related support to physician practices in disease areas including oncology.[P-94f72957cad24fc58c8604bde56699db] In animal health, its product set includes pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other veterinary products.[P-0623a7e8fdb84428a1fbe8e5d59752d5]\n\nIts service portfolio includes both provider-facing and manufacturer-facing offerings. Cencora lists data analytics, outcomes research, reimbursement and pharmaceutical consulting, regulatory affairs, development consulting, scientific affairs, pharmacovigilance, quality management and compliance, niche premium logistics, inventory management, pharmacy automation, pharmacy management, and packaging solutions.[P-6a5e1f3536af4dfe80c9097267866630][P-4c928ece93fd48f2ac141719696657fd] For manufacturers, it also provides support for new product launches, promotional and marketing services, product-data reporting, market access, health-economics consulting, patient-support programs, contract field staffing, patient assistance and copay support, adherence programs, risk-mitigation services, and logistical support.[P-6ce66e956d1f41fa83aaacc9b7bb6d8b][P-899d34f9185649bba0e9473b2f8e0b3c] In animal health, those services extend to e-commerce tools, technology management systems, pharmacy fulfillment, inventory management, equipment procurement consultation, special-order fulfillment, and educational seminars.[P-0890552250d64cc1bb117d8e313d35c0]\n\nNamed offerings on Cencora’s website include Provider Solutions for specialty practices, Accelerate Pharmacy Solutions, Accelerate Specialty Network, Cencora eBenefits Services, covered-entity/340B services, and logistics and warehousing services that include specialty logistics, transport solutions, packaging and labeling, and third-party logistics.[https://www.cencora.com/human-health/our-capabilities/provider-solutions][https://www.cencora.com/solutions/accelerate-pharmacy-solutions][https://www.cencora.com/solutions/accelerate-specialty-network][https://www.cencora.com/solutions/cencora-ebenefits-services][https://www.cencora.com/solutions/covered-entity][https://www.cencora.com/our-capabilities/logistics-and-warehousing][https://www.cencora.com/our-capabilities/logistics-and-warehousing/specialty-logistics][https://www.cencora.com/our-capabilities/logistics-and-warehousing/transport-solutions][https://www.cencora.com/our-capabilities/logistics-and-warehousing/packaging-and-labeling][https://www.cencora.com/our-capabilities/logistics-and-warehousing/third-party-logistics] Operationally, Cencora says it serves customers through a geographically diverse network of distribution service centers and a national distribution center in Columbus, Ohio, and that it continues to invest in warehouse automation.[P-92301cfdf7394b2199445a8b2c1affb7][P-5043e34375754922b911e0c63d41b1e9] By reported segment rather than by individual product line, FY2024 revenue was 90.3% U.S. Healthcare Solutions, including 88.4% Human Health and 1.8% Animal Health, with 9.7% from International Healthcare Solutions.[T-1ca99d4fc7834c10b280ee291e133488]\n[P-6a5e1f3536af4dfe80c9097267866630][P-94f72957cad24fc58c8604bde56699db][P-0623a7e8fdb84428a1fbe8e5d59752d5][P-4c928ece93fd48f2ac141719696657fd][P-6ce66e956d1f41fa83aaacc9b7bb6d8b][P-899d34f9185649bba0e9473b2f8e0b3c][P-0890552250d64cc1bb117d8e313d35c0][P-92301cfdf7394b2199445a8b2c1affb7][P-5043e34375754922b911e0c63d41b1e9][T-1ca99d4fc7834c10b280ee291e133488][https://www.cencora.com/human-health/our-capabilities/provider-solutions][https://www.cencora.com/solutions/accelerate-pharmacy-solutions][https://www.cencora.com/solutions/accelerate-specialty-network][https://www.cencora.com/solutions/cencora-ebenefits-services][https://www.cencora.com/solutions/covered-entity][https://www.cencora.com/our-capabilities/logistics-and-warehousing][https://www.cencora.com/our-capabilities/logistics-and-warehousing/specialty-logistics][https://www.cencora.com/our-capabilities/logistics-and-warehousing/transport-solutions][https://www.cencora.com/our-capabilities/logistics-and-warehousing/packaging-and-labeling][https://www.cencora.com/our-capabilities/logistics-and-warehousing/third-party-logistics]",
      "updatedAt": "2026-03-19T06:14:10.735834Z"
    },
    {
      "type": "GEOGRAPHY",
      "text": "Cencora’s operations are organized into two reportable geographic businesses: U.S. Healthcare Solutions and International Healthcare Solutions. The company says it serves customers through a geographically diverse network of distribution service centers and other operations in the United States and select global markets, with the international business operating primarily in Europe and also including Canada.[P-8128efc457644950aee236911b2db1a3][P-92301cfdf7394b2199445a8b2c1affb7][P-4c928ece93fd48f2ac141719696657fd]\n\nIn fiscal 2024, the U.S. business accounted for the large majority of revenue: U.S. Healthcare Solutions generated $265.3 billion and International Healthcare Solutions generated $28.6 billion, or roughly 90% and 10% of total revenue, respectively, before immaterial intersegment eliminations.[T-4a61a9f38a33463ab15be5df3f1fd331] The company also disclosed pre-tax income of $1.289 billion from domestic operations and $0.715 billion from foreign operations.[T-3b2e5f26cb714dd8a630bfe150604baf]\n\nCencora’s principal executive offices are in Conshohocken, Pennsylvania.[T-b6389479700643a3bf75f2fe5e9cf3ba] Additional geographic references in company disclosures indicate operations or regulatory exposure in countries including China, India and Turkey, and a generic private-label program based in Ireland.[P-177b2811896b44eb821833cbdacd2b07][P-34ebaaaaa42b450ab7bb24736d46c3f4] Separately, Cencora’s corporate responsibility materials state that it has more than 46,000 team members across more than 50 countries.[https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-overview-fnl.pdf]\n[P-8128efc457644950aee236911b2db1a3][P-92301cfdf7394b2199445a8b2c1affb7][P-4c928ece93fd48f2ac141719696657fd][T-4a61a9f38a33463ab15be5df3f1fd331][T-3b2e5f26cb714dd8a630bfe150604baf][T-b6389479700643a3bf75f2fe5e9cf3ba][P-177b2811896b44eb821833cbdacd2b07][P-34ebaaaaa42b450ab7bb24736d46c3f4][https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-overview-fnl.pdf]",
      "updatedAt": "2026-03-19T06:14:10.735834Z"
    },
    {
      "type": "SEGMENTS",
      "text": "Cencora reports two official reportable segments, organized geographically: U.S. Healthcare Solutions and International Healthcare Solutions. U.S. Healthcare Solutions includes the company’s U.S. pharmaceutical distribution and related services activities, including distribution of brand, specialty brand and generic pharmaceuticals, OTC products, home healthcare supplies and equipment, physician-office distribution, data analytics, pharmacy management and consulting, manufacturer services, packaging solutions, and animal health products and services. International Healthcare Solutions covers international pharmaceutical wholesale and related services, along with global commercialization services, including distribution primarily in Europe, specialty transportation and logistics for biopharma, regulatory and scientific support services, pharmacovigilance, quality/compliance services, and Canadian supply-chain partnerships. [P-392763800a254a59ae9fe0d0ec969fff][P-e4f6714379574fc097ec78b0e3f4c036][P-881f1ebfe5ef4380ae4e64c9f76ad4a8][P-72b31598fb944aab85f48e32bc1bfeae]\n\nBased on FY2024 revenue, U.S. Healthcare Solutions contributed about 90% of total revenue ($265.3 billion of $294.0 billion), while International Healthcare Solutions contributed about 10% ($28.6 billion). On a segment operating income basis, the mix was somewhat less concentrated: U.S. Healthcare Solutions contributed about 81% and International Healthcare Solutions about 20% of total segment operating income in FY2024. [T-4a61a9f38a33463ab15be5df3f1fd331][T-e397748ee3614b39a2c33f9fae56e8a7]\n\nCencora also discloses a secondary revenue breakdown within those segments. Within U.S. Healthcare Solutions, Human Health accounted for about 88.4% of consolidated revenue in FY2024 and Animal Health about 1.8%. Within International Healthcare Solutions, Alliance Healthcare accounted for about 7.8% of consolidated revenue and Other Healthcare Solutions about 1.9%. These are revenue categories within the two reportable segments rather than separate reportable segments, and the percentages do not sum exactly to 100% because of intersegment eliminations. [T-4a61a9f38a33463ab15be5df3f1fd331]\n[P-392763800a254a59ae9fe0d0ec969fff][P-e4f6714379574fc097ec78b0e3f4c036][P-881f1ebfe5ef4380ae4e64c9f76ad4a8][P-72b31598fb944aab85f48e32bc1bfeae][T-4a61a9f38a33463ab15be5df3f1fd331][T-e397748ee3614b39a2c33f9fae56e8a7]",
      "updatedAt": "2026-03-19T06:14:10.735834Z"
    },
    {
      "type": "HISTORY",
      "text": "Cencora traces part of its heritage to 1871, when Lucien Napoleon Brunswig entered the drug wholesale trade, and to 1907, when the Brunswig Drug Company focused exclusively on wholesale drug distribution.[https://www.cencora.com/about/history] The modern company was formed in 2001 through the combination of AmeriSource Health and Bergen Brunswig, creating AmerisourceBergen.[https://investor.amerisourcebergen.com/news/news-details/2001/AmeriSource-and-Bergen-Brunswig-to-Combine-Creating-a-35-Billion-Healthcare-Services-Company/default.aspx][https://www.cencora.com/about/history]\n\nAmerisourceBergen expanded its platform in the following decade through both leadership and portfolio changes. Steven H. Collis succeeded R. David Yost as chief executive in July 2011.[https://investor.cencora.com/news/news-details/2011/AmerisourceBergen-CEO-Dave-Yost-to-Retire-Steve-Collis-Named--Successor/default.aspx] In 2012, the company acquired World Courier, adding a global specialty transportation and logistics business for the biopharmaceutical industry, and in 2015 it acquired MWI Veterinary Supply, extending further into animal health distribution.[https://www.worldcourier.com/news-and-events/press-releases/amerisourcebergen-acquires-world-courier][https://www.mwiah.com/newsroom/press-releases/amerisourcebergen-to-acquire-mwi-veterinary-supply]\n\nThe company continued to broaden its geographic reach in 2021 by completing the acquisition of most of Walgreens Boots Alliance’s Alliance Healthcare businesses.[https://investor.amerisourcebergen.com/news/news-details/2021/AmerisourceBergen-Completes-Acquisition-of-Alliance-Healthcare-Businesses/default.aspx] In 2023, AmerisourceBergen changed its corporate name to Cencora, a rebranding the company described as aligning with its growing global footprint.[https://www.cencora.com/newsroom/amerisourcebergen-becomes-cencora][https://www.cencora.com/about/history] In 2024, Collis transitioned from CEO to executive chair and Robert P. Mauch became president and CEO.[https://www.cencora.com/newsroom/cencora-announces-leadership-succession-plan]\n[https://www.cencora.com/about/history][https://investor.amerisourcebergen.com/news/news-details/2001/AmeriSource-and-Bergen-Brunswig-to-Combine-Creating-a-35-Billion-Healthcare-Services-Company/default.aspx][https://investor.cencora.com/news/news-details/2011/AmerisourceBergen-CEO-Dave-Yost-to-Retire-Steve-Collis-Named--Successor/default.aspx][https://www.worldcourier.com/news-and-events/press-releases/amerisourcebergen-acquires-world-courier][https://www.mwiah.com/newsroom/press-releases/amerisourcebergen-to-acquire-mwi-veterinary-supply][https://investor.amerisourcebergen.com/news/news-details/2021/AmerisourceBergen-Completes-Acquisition-of-Alliance-Healthcare-Businesses/default.aspx][https://www.cencora.com/newsroom/amerisourcebergen-becomes-cencora][https://www.cencora.com/newsroom/cencora-announces-leadership-succession-plan]",
      "updatedAt": "2026-03-19T06:14:10.735834Z"
    }
  ],
  "sources": [
    {
      "id": "P-6a5e1f3536af4dfe80c9097267866630",
      "href": "https://app.finbar.com/go?id=P-6a5e1f3536af4dfe80c9097267866630",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-4ada030b0cd84eb2af4fb7ad86086b3f",
      "href": "https://app.finbar.com/go?id=P-4ada030b0cd84eb2af4fb7ad86086b3f",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-b76378d9a8db4333aba49654008953ec",
      "href": "https://app.finbar.com/go?id=P-b76378d9a8db4333aba49654008953ec",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "https://www.cencora.com/about",
      "href": "https://www.cencora.com/about",
      "label": "www.cencora.com"
    },
    {
      "id": "T-4a61a9f38a33463ab15be5df3f1fd331",
      "href": "https://app.finbar.com/go?id=T-4a61a9f38a33463ab15be5df3f1fd331",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "https://www.cencora.com/global-reach",
      "href": "https://www.cencora.com/global-reach",
      "label": "www.cencora.com"
    },
    {
      "id": "P-22e2057c33174f1aa773e4814d8b4a30",
      "href": "https://app.finbar.com/go?id=P-22e2057c33174f1aa773e4814d8b4a30",
      "label": "Cencora, Inc. — Press release (2023 Y)",
      "documentId": "D-045df5600a0d4fee875b01fd8aa4bd07"
    },
    {
      "id": "P-94f72957cad24fc58c8604bde56699db",
      "href": "https://app.finbar.com/go?id=P-94f72957cad24fc58c8604bde56699db",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-0623a7e8fdb84428a1fbe8e5d59752d5",
      "href": "https://app.finbar.com/go?id=P-0623a7e8fdb84428a1fbe8e5d59752d5",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-4c928ece93fd48f2ac141719696657fd",
      "href": "https://app.finbar.com/go?id=P-4c928ece93fd48f2ac141719696657fd",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-6ce66e956d1f41fa83aaacc9b7bb6d8b",
      "href": "https://app.finbar.com/go?id=P-6ce66e956d1f41fa83aaacc9b7bb6d8b",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-899d34f9185649bba0e9473b2f8e0b3c",
      "href": "https://app.finbar.com/go?id=P-899d34f9185649bba0e9473b2f8e0b3c",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-0890552250d64cc1bb117d8e313d35c0",
      "href": "https://app.finbar.com/go?id=P-0890552250d64cc1bb117d8e313d35c0",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "https://www.cencora.com/human-health/our-capabilities/provider-solutions",
      "href": "https://www.cencora.com/human-health/our-capabilities/provider-solutions",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/solutions/accelerate-pharmacy-solutions",
      "href": "https://www.cencora.com/solutions/accelerate-pharmacy-solutions",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/solutions/accelerate-specialty-network",
      "href": "https://www.cencora.com/solutions/accelerate-specialty-network",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/solutions/cencora-ebenefits-services",
      "href": "https://www.cencora.com/solutions/cencora-ebenefits-services",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/solutions/covered-entity",
      "href": "https://www.cencora.com/solutions/covered-entity",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/our-capabilities/logistics-and-warehousing",
      "href": "https://www.cencora.com/our-capabilities/logistics-and-warehousing",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/specialty-logistics",
      "href": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/specialty-logistics",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/transport-solutions",
      "href": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/transport-solutions",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/packaging-and-labeling",
      "href": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/packaging-and-labeling",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/third-party-logistics",
      "href": "https://www.cencora.com/our-capabilities/logistics-and-warehousing/third-party-logistics",
      "label": "www.cencora.com"
    },
    {
      "id": "P-92301cfdf7394b2199445a8b2c1affb7",
      "href": "https://app.finbar.com/go?id=P-92301cfdf7394b2199445a8b2c1affb7",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-5043e34375754922b911e0c63d41b1e9",
      "href": "https://app.finbar.com/go?id=P-5043e34375754922b911e0c63d41b1e9",
      "label": "Cencora, Inc. — Full financial report (2023 Y)",
      "documentId": "D-b65109bbeb8f43cda8b46608431cf207"
    },
    {
      "id": "T-1ca99d4fc7834c10b280ee291e133488",
      "href": "https://app.finbar.com/go?id=T-1ca99d4fc7834c10b280ee291e133488",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-8128efc457644950aee236911b2db1a3",
      "href": "https://app.finbar.com/go?id=P-8128efc457644950aee236911b2db1a3",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "T-3b2e5f26cb714dd8a630bfe150604baf",
      "href": "https://app.finbar.com/go?id=T-3b2e5f26cb714dd8a630bfe150604baf",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "T-b6389479700643a3bf75f2fe5e9cf3ba",
      "href": "https://app.finbar.com/go?id=T-b6389479700643a3bf75f2fe5e9cf3ba",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-177b2811896b44eb821833cbdacd2b07",
      "href": "https://app.finbar.com/go?id=P-177b2811896b44eb821833cbdacd2b07",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-34ebaaaaa42b450ab7bb24736d46c3f4",
      "href": "https://app.finbar.com/go?id=P-34ebaaaaa42b450ab7bb24736d46c3f4",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-overview-fnl.pdf",
      "href": "https://esg.cencora.com/-/media/assets/corporate-responsibility/reports/24-ent-00435-cr-overview-fnl.pdf",
      "label": "esg.cencora.com"
    },
    {
      "id": "P-392763800a254a59ae9fe0d0ec969fff",
      "href": "https://app.finbar.com/go?id=P-392763800a254a59ae9fe0d0ec969fff",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-e4f6714379574fc097ec78b0e3f4c036",
      "href": "https://app.finbar.com/go?id=P-e4f6714379574fc097ec78b0e3f4c036",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-881f1ebfe5ef4380ae4e64c9f76ad4a8",
      "href": "https://app.finbar.com/go?id=P-881f1ebfe5ef4380ae4e64c9f76ad4a8",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "P-72b31598fb944aab85f48e32bc1bfeae",
      "href": "https://app.finbar.com/go?id=P-72b31598fb944aab85f48e32bc1bfeae",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "T-e397748ee3614b39a2c33f9fae56e8a7",
      "href": "https://app.finbar.com/go?id=T-e397748ee3614b39a2c33f9fae56e8a7",
      "label": "Cencora, Inc. — Full financial report (2024 Y)",
      "documentId": "D-8318fdef740f4f77afac2741baf31156"
    },
    {
      "id": "https://www.cencora.com/about/history",
      "href": "https://www.cencora.com/about/history",
      "label": "www.cencora.com"
    },
    {
      "id": "https://investor.amerisourcebergen.com/news/news-details/2001/AmeriSource-and-Bergen-Brunswig-to-Combine-Creating-a-35-Billion-Healthcare-Services-Company/default.aspx",
      "href": "https://investor.amerisourcebergen.com/news/news-details/2001/AmeriSource-and-Bergen-Brunswig-to-Combine-Creating-a-35-Billion-Healthcare-Services-Company/default.aspx",
      "label": "investor.amerisourcebergen.com"
    },
    {
      "id": "https://investor.cencora.com/news/news-details/2011/AmerisourceBergen-CEO-Dave-Yost-to-Retire-Steve-Collis-Named--Successor/default.aspx",
      "href": "https://investor.cencora.com/news/news-details/2011/AmerisourceBergen-CEO-Dave-Yost-to-Retire-Steve-Collis-Named--Successor/default.aspx",
      "label": "investor.cencora.com"
    },
    {
      "id": "https://www.worldcourier.com/news-and-events/press-releases/amerisourcebergen-acquires-world-courier",
      "href": "https://www.worldcourier.com/news-and-events/press-releases/amerisourcebergen-acquires-world-courier",
      "label": "www.worldcourier.com"
    },
    {
      "id": "https://www.mwiah.com/newsroom/press-releases/amerisourcebergen-to-acquire-mwi-veterinary-supply",
      "href": "https://www.mwiah.com/newsroom/press-releases/amerisourcebergen-to-acquire-mwi-veterinary-supply",
      "label": "www.mwiah.com"
    },
    {
      "id": "https://investor.amerisourcebergen.com/news/news-details/2021/AmerisourceBergen-Completes-Acquisition-of-Alliance-Healthcare-Businesses/default.aspx",
      "href": "https://investor.amerisourcebergen.com/news/news-details/2021/AmerisourceBergen-Completes-Acquisition-of-Alliance-Healthcare-Businesses/default.aspx",
      "label": "investor.amerisourcebergen.com"
    },
    {
      "id": "https://www.cencora.com/newsroom/amerisourcebergen-becomes-cencora",
      "href": "https://www.cencora.com/newsroom/amerisourcebergen-becomes-cencora",
      "label": "www.cencora.com"
    },
    {
      "id": "https://www.cencora.com/newsroom/cencora-announces-leadership-succession-plan",
      "href": "https://www.cencora.com/newsroom/cencora-announces-leadership-succession-plan",
      "label": "www.cencora.com"
    }
  ]
}